Goldberg publishes research on the efficacy of bempedoic acid in those with hypercholesterolemia 

On May 1, Anne Carol Goldberg, MD, FACP, FAHA, FNLA and colleagues had their research titled “Efficacy and safety of bempedoic acid in patients not receiving statins in phase 3 clinical trials,” published in the “Journal of Clinical Lipidology.”  “Despite the high incidence of patients with statin tolerance problems, randomized evaluations of nonstatin oral treatment […]

Parham and Goldberg publish review on bempedoic acid and inclisiran treatment 

In August, Johnathon Seth Parham, MD and Anne Carol Goldberg, MD, FACP had their review titled “Major Concepts in Treatment with Bempedoic Acid and Inclisiran that Clinicians Need To Know,” published in “Current Atherosclerosis Reports.”  The review looks at two new lipid-lowering treatment medications, bempedoic acid and inclisiran. “Bempedoic acid inhibits adenosine citrate lyase, decreasing […]